Inter-alpha-trypsin-inhibitor (ITI): two distinct mRNAs in baboon liver argue for a discrete synthesis of ITI and ITI derivatives.
Human serum inter-alpha-trypsin-inhibitor (ITI) has so far been assumed to be comprised of a single polypeptide chain which can undergo fragmentation, whereby inhibitory ITI derivatives are released into the blood stream. In contrast, the analysis of the baboon liver mRNA translation products showed that ITI is made up of heavy and light chain(s). The latter may be excreted independently and very likely corresponds to the so-called ITI derivatives.
D000510:Alpha-Globulins / Q000096:biosynthesis* / Q000235:genetics; D000818:Animals; D002474:Cell-Free System; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D007120:Immunochemistry; D008099:Liver / Q000378:metabolism*; D010215:Papio; D010446:Peptide Fragments / Q000096:biosynthesis / Q000302:isolation & purification; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000302:isolation & purification*; D011817:Rabbits; D014361:Trypsin Inhibitors / Q000096:biosynthesis* / Q000235:genetics
D000510:Alpha-Globulins; D010446:Peptide Fragments; D012333:RNA, Messenger; D014361:Trypsin Inhibitors; C011877:inter-alpha-inhibitor